Evaluation of a novel real-time PCR test based on the ssrA gene for the identification of group B streptococci in vaginal swabs

Martina Wernecke, Ciara Mullen, Vimla Sharma, John Morrison, Thomas Barry, Majella Maher, Terry Smith, Martina Wernecke, Ciara Mullen, Vimla Sharma, John Morrison, Thomas Barry, Majella Maher, Terry Smith

Abstract

Background: Despite the implementation of prevention guidelines, early-onset group B streptococci (GBS) disease remains a cause of neonatal morbidity and mortality worldwide. Strategies to identify women who are at risk of transmitting GBS to their infant and the administration of intrapartum antibiotics have greatly reduced the incidence of neonatal GBS disease. However, there is a requirement for a rapid diagnostic test for GBS that can be carried out in a labour ward setting especially for women whose GBS colonisation status is unknown at the time of delivery. We report the design and evaluation of a real-time PCR test (RiboSEQ GBS test) for the identification of GBS in vaginal swabs from pregnant women.

Methods: The qualitative real-time PCR RiboSEQ GBS test was designed based on the bacterial ssrA gene and incorporates a competitive internal standard control. The analytical sensitivity of the test was established using crude lysate extracted from serial dilutions of overnight GBS culture using the IDI Lysis kit. Specificity studies were performed using DNA prepared from a panel of GBS strains, related streptococci and other species found in the genital tract environment. The RiboSEQ GBS test was evaluated on 159 vaginal swabs from pregnant women and compared with the GeneOhm StrepB Assay and culture for the identification of GBS.

Results: The RiboSEQ GBS test is specific and has an analytical sensitivity of 1-10 cell equivalents. The RiboSEQ GBS test was 96.4% sensitive and 95.8% specific compared to "gold standard" culture for the identification of GBS in vaginal swabs from pregnant women. In this study, the RiboSEQ GBS test performed slightly better than the commercial BD GeneOhm StrepB Assay which gave a sensitivity of 94.6% and a specificity of 89.6% compared to culture.

Conclusion: The RiboSEQ GBS test is a valuable method for the rapid, sensitive and specific detection of GBS in pregnant women. This study also validates the ssrA gene as a suitable and versatile target for nucleic acid-based diagnostic tests for bacterial pathogens.

References

    1. Centers for Disease Control and Prevention (CDC) Diminishing racial disparities in early-onset neonatal group B streptococcal disease--United States, 2000-2003. Morb Mortal Wkly Rep. 2004;53:502–505.
    1. Centres for Disease Control and Prevention (CDC) Prevention of perinatal group B streptococcal disease. Morb Mortal Wkly Rep. 2002;51:1–6.
    1. Meyn LA, Moore DM, Hillier SL, Krohn MA. Association of sexual activity with colonisation and vaginal acquisition of group B Streptococcus in nonpregnant women. Am J Epidemiol. 2002;155:949–957. doi: 10.1093/aje/155.10.949.
    1. Elbaradie SMY, Mahmoud M, Farid M. Maternal and neonatal screening for group B Streptococci by scpB gene based PCR: A preliminary study. Ind J Med Microbiol. 2009;27:17–21.
    1. Castor ML, Whitney GC, Como-Sabetti K, Facklam RR, Ferrieri P, Bartkus JM, Juni BA, Cieslak PR, Farley MM, Dumas NB, Schrag SJ, Lynfield R. Antibiotic resistance pattern in invasive group B streptococcal isolates. Infect Dis Obstet Gynecol. 2008.
    1. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. Morb Mortal Wkly Rep. 1992;41(SS-6):25–32.
    1. Royal College of Obstetricians and Gynaecologists (RCOG) Green-top Guideline. Vol. 36. London: RCOG; 2003. Prevention of Early-onset Neonatal Group B Streptococcal Disease.
    1. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, Harrison LH, Reingold A, Stefonek K, Smith G, Gamble M, Schuchat A. Active Bacterial Core Surveillance Team. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 2002;347:233–239. doi: 10.1056/NEJMoa020205.
    1. Colbourn T, Asseburg C, Bojke L, Philips Z, Claxton K, Ades AE, Gilbert RE. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy; cost effectiveness and expected value of information analysis. Health Technol Assess. 2007;11:1–226iii.
    1. Daley AJ, Garland SM. Prevention of neonatal Group B streptococcal disease: Progress, challenges and dilemmas. J Paediatr Child Health. 2004;40:664–668. doi: 10.1111/j.1440-1754.2004.00507.x.
    1. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, Hadler JL, Danila R, Cieslak PR, Schuchat A. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342:15–20. doi: 10.1056/NEJM200001063420103.
    1. Puopolo KM, Madoff LC, Eichenwald EC. Early-Onset Group B Streptococcal Disease in the Era of Maternal Screening. Pediatrics. 2005;115:1240–1246. doi: 10.1542/peds.2004-2275.
    1. Convert M, Martinetti Lucchini G, Dolina M, Piffaretti JC. Comparison of LightCycler PCR and culture for detection of group B streptococci from vaginal swabs. Clin Microbiol Infect. 2005;11:1022–1026. doi: 10.1111/j.1469-0691.2005.01275.x.
    1. Davies HD, Miller MA, Faro S, Gregson D, Kehl SC, Jordan JA. Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. Clin Infect Dis. 2004;39:1129–1135. doi: 10.1086/424518.
    1. Gavino M, Wang E. A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B streptococcus colonisation. Am J Obstet Gynecol. 2007;197:e1–388e4. doi: 10.1016/j.ajog.2007.06.016.
    1. Goodrich JS, Miller MB. Comparison of culture and 2 real-time polymerase chain reaction assays to detect group B Streptococcus during antepartum screening. Diagn Microbiol Infect Dis. 2007;59:17–22. doi: 10.1016/j.diagmicrobio.2007.03.023.
    1. Rallu F, Barriga P, Scrivo C, Martel-Laferrière V, Laferrière C. Sensitivities of antigen detection and PCR assays greatly increased compared to that of the standard culture method for screening for group B Streptococcus carriage in pregnant women. J Clin Microbiol. 2006;44(3):725–728. doi: 10.1128/JCM.44.3.725-728.2006.
    1. Glynn B, Lahiff S, Wernecke M, Barry T, Smith TJ, Maher M. Current and emerging molecular diagnostic technologies applicable to bacterial food safety. Int J Dairy Technol. 2006;59:126–139. doi: 10.1111/j.1471-0307.2006.00253.x.
    1. O'Grady J, Sedano-Balbás S, Maher M, Smith T, Barry T. Rapid real-time PCR detection of Listeria monocytogenes in enriched food samples based on the ssrA gene, a novel diagnostic target. Food Microbiol. 2008;25(1):75–84. doi: 10.1016/j.fm.2007.07.007.
    1. Hoorfar J, Ahrens P, Rådström P. Automated 5' nuclease PCR assay for identification of Salmonella enterica. J Clin Microbiol. 2000;38(9):3429–3435.
    1. Hoorfar J, Malorny B, Abdulmawjood A, Cook N, Wagner M, Fach P. Practical considerations in design of internal amplification controls for diagnostic PCR assays. J Clin Microbiol. 2004;42:1863–1868. doi: 10.1128/JCM.42.5.1863-1868.2004.
    1. Williams KP. The tmRNA website. Nucleic Acids Res. 2000;28:168–170. doi: 10.1093/nar/28.1.168.
    1. Honest H, Sharma S, Khan KS. Rapid tests for Group B Streptococcus colonisation in laboring women: a systematic review. Pediatrics. 2006;117:1055–1066. doi: 10.1542/peds.2005-1114.
    1. Bergeron MG, Ke D, Ménard C, Francois FJ, Gagnon M, Bernier M, Ouellette M, Roy PH, Marcoux S, Fraser WD. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med. 2000;343:175–179. doi: 10.1056/NEJM200007203430303.
    1. Ke D, Menard C, Picard FJ, Boissinot M, Ouellette M, Roy PH, Bergeron MG. Development of conventional and real-time PCR assays for the rapid detection of group B streptococci. Clin Chem. 2000;46(3):324–331.
    1. Lamy MC, Dramsi S, Billoët A, Réglier-Poupet H, Tazi A, Raymond J, Guérin F, Couvé E, Kunst F, Glaser P, Trieu-Cuot P, Poyart C. Rapid detection of the "highly virulent" group B Streptococcus ST-17 clone. Microbes Infect. 2006;8:1714–1722. doi: 10.1016/j.micinf.2006.02.008.
    1. Uhl JR, Vetter EA, Boldt KL, Johnston BW, Ramin KD, Adams MJ, Ferrieri P, Reischl U, Cockerill FR. Use of the Roche LightCycler Strep B Assay for detection of Group B Streptococcus from vaginal and rectal swabs. J Clin Microbiol. 2005;43:4046–4051. doi: 10.1128/JCM.43.8.4046-4051.2005.
    1. Van der Mee-Marquet N, Jouannet C, Domelier AS, Arnault L, Lartique MF, Quentin R. Genetic diversity of Streptococcus agalactiae strains and density of vaginal carriage. J Med Microbiol. 2009;58:169–173. doi: 10.1099/jmm.0.005827-0.
    1. Bergseng H, Bevanger L, Rygg M, Bergh K. Real-time PCR targeting the sip gene for detection of group B streptcoccus colonisation in pregnant women at delivery. J Med Microbiol. 2007;56:223–228. doi: 10.1099/jmm.0.46731-0.
    1. Dunne WM Jr, Holland-Staley CA. Comparison of NNA agar culture and selective broth culture for detection of group B streptococcal colonisation in women. J Clin Microbiol. 1998;36:2298–2300.
    1. Ostroff RM, Steaffens JW. Effect of specimen storage, antibiotics, and feminine hygiene products on the detection of group B streptococcus by culture and the STREP B OIA test. Diagn Microbiol Infect Dis. 1995;22:253–259. doi: 10.1016/0732-8893(95)00046-D.
    1. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonisation at delivery. Obstet Gynecol. 1996;88:811–815. doi: 10.1016/0029-7844(96)00320-1.
    1. Boschert S. Fast, point-of-care Group B Strep test gets FDA approval: labor and delivery nurses can perform it. Ob Gyn News. 2006;41:1.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe